Carbamazepine: Placental Transport, Tissue Concentrations in Foetus and Newborn, and Level in Milk
- 1 September 1977
- journal article
- research article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 41 (3), 244-253
- https://doi.org/10.1111/j.1600-0773.1977.tb02145.x
Abstract
Carbamazepine pharmacokinetics, in humans, were studied during pregnancy and early childhood by investigating the extent of its placental penetration and its distribution in the fetal and neonatal tissues at autopsy. Fetal liver and kidney contained high carbamazepine levels, whereas brain and lungs had low values. Carbamazepine-10,11-epoxide was detected in fetal circulation. At autopsy, carbamazepine was localized mostly in the cerebral cortex, heart, liver and kidney. The concentration in milk apparently was 60% of the respective plasma value. [Carbamazine penetrates the human placental barrier and may cause congenital malformations.].Keywords
This publication has 18 references indexed in Scilit:
- Placental transfer of carbamazepine in the ratJournal of Pharmacy and Pharmacology, 1975
- Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. I. Differences in mutagenicityInternational Journal of Cancer, 1975
- Drug metabolism in the human neonateLife Sciences, 1975
- Pharmacokinetic Data of Carbamazepine and Its Major Metabolites in ManPublished by Springer Nature ,1975
- Plasma disappearance of transplacentally transferred diphenylhydantoin in the newborn studied by mass fragmentographyClinical Pharmacology & Therapeutics, 1974
- Drug metabolism by placentaClinical Pharmacology & Therapeutics, 1973
- PHENYTOIN TERATOGENICITY IN MANThe Lancet, 1973
- Carbamazepine plasma and tissue levels in the ratBiochemical Pharmacology, 1971
- Diphenylhydantoin: Placental transport, fetallocalization, neonatal metabolism, and possible teratogenic effectsThe Journal of Pediatrics, 1971
- The effect of growth and function on the chemical composition of soft tissuesBiochemical Journal, 1960